{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-148134","form_type":"8-K","ticker":"FNCHQ","cik":"0001733257","company_name":"Finch Therapeutics Group, Inc.","filed_at":"2023-05-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.286561+00:00","generated_at":"2026-06-14T21:21:31.836313+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Finch Therapeutics enters contingent lease termination agreement for Somerville facility","bullets":["Lease termination contingent on landlord signing new tenant lease for 36,285 sq ft at 200 Inner Belt Road, Somerville.","Termination date would be later of May 31, 2023 or three days after new lease execution.","If no new lease by June 30, 2023, agreement void and lease continues through September 2026.","Security deposit of $199,467 to be returned to Finch upon termination and surrender of premises.","Company represents no active subleases; prior sublease to Microbiome Health Research Institute has expired."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-148134","json":"https://secwatch.observer/filing/0001193125-23-148134.json","markdown":"https://secwatch.observer/filing/0001193125-23-148134.md","text":"https://secwatch.observer/filing/0001193125-23-148134.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1733257/000119312523148134/0001193125-23-148134-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1733257/000119312523148134/d495512d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T21:21:31.836313+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"903c487c2926c7b42109c85d12ba822cb17a26a1","claim":"Finch Therapeutics Group, Inc. terminated Lease Termination Agreement with NRL WCS 200 Inner Belt Prop, LLC (effective 2023-05-12).","evidence_excerpt":"On May 12, 2023, Finch Therapeutics Group, Inc. (the “Company”) entered into a Lease Termination Agreement (the “Agreement”) with NRL WCS 200 Inner Belt Prop, LLC, a Delaware limited liability company (the “Landlord”), related to the office lease agreement","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1733257/000119312523148134/0001193125-23-148134-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"lease"},{"label":"Counterparty","value":"NRL WCS 200 Inner Belt Prop, LLC"},{"label":"Effective","value":"2023-05-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}